Sleeve Rescue Plus™
Rescue + Enhanced Metabolic Power.
Restore restriction and add advanced metabolic power for renewed weight loss and metabolic control.
What is Sleeve Rescue Plus™?
Sleeve Rescue Plus™ addresses weight regain after initial sleeve (common in 20–50% of patients), combining re-sleeve or plication with optional metabolic enhancement.
Who it's for: Patients who experienced significant regain or insufficient loss after an initial sleeve gastrectomy.
- Correct weight regain and restore restriction
- Add advanced metabolic power for renewed results
- Proven revision expertise at OCC
- Faster recovery options for international patients
A clear, precise pathway.
- 01
Assessment & calibration
Comprehensive imaging and endoscopy define the right revision strategy.
- 02
Re-sleeve or plication
Restore restriction and gastric volume through precision revision.
- 03
Optional metabolic enhancement
Add an advanced duodeno-ileal anastomosis for renewed metabolic power.
- 04
Recovery & long-term support
Personalized nutrition with MyProgressMD restores progress.
Ready for Rescue + Enhanced Metabolic Power?
Speak with our international care team today — same-week availability.
The science behind Sleeve Rescue Plus™.
Amplify your results with science-backed protocols.
Pair Sleeve Rescue Plus™ with personalized pre- and post-op bundles from MyProgressMD — engineered to support healing, nutrition, and long-term metabolic outcomes.
Shop Supplement BundlesCurrent Evidence Status
A transparent snapshot of the regulatory, clinical, and research evidence currently available for this procedure. Published evidence continues to evolve; long-term studies remain ongoing.
- FDA Regulatory Status— De Novo + 510(k) clearances Available
- Human Studies Published
- Peer-Reviewed Publications Published
- Long-Term Data (>5 years)— Follow-up ongoing Limited
- Ongoing Clinical Trials— Chile and Italy registries Active
Scientific References
Selected primary sources informing this page. External links open in a new tab; we do not control or endorse third-party content.
- FDAU.S. FDA — De Novo Classification DEN240013: MagDI System (Magnetic Duodeno-Ileostomy), De Novo marketing authorization granted July 2, 2024.
- FDAU.S. FDA — 510(k) Premarket Notification K242086: MagDI System (second generation), clearance granted October 24, 2024.
- SOARDMagnetic duodeno-ileal anastomosis after previous sleeve gastrectomy for weight regain, insufficient weight loss, or diabetes recurrence. Surgery for Obesity and Related Diseases (SOARD).
- Surgical EndoscopyMulti-center early outcomes of sleeve gastrectomy combined with magnetic duodeno-ileostomy (Sleeve Plus MagDI). Surgical Endoscopy.
- ASMBSAmerican Society for Metabolic and Bariatric Surgery (ASMBS) and IFSO 2022 indications for metabolic and bariatric surgery.
Frequently asked questions
Your next step starts here.
Our international care team typically responds within one business day. WhatsApp available 24/7 for urgent inquiries.
Choose Rescue + Enhanced Metabolic Power. Start today.
Limited slots for international patients. Same-week availability from San Diego.